The capacity crunch in biopharma is a location problem
Cell and gene therapies aren’t limited by ideas—they’re limited by where they’re built. See how “ready-now” locations change...
Cell and gene therapies aren’t limited by ideas—they’re limited by where they’re built. See how “ready-now” locations change the math on scaling.